Tuesday, March 17, 2026

Cigarettes vs. DNA: Study Shows Smoking Is the Real Cancer Trigger

A study shows that smoking for over 20 years increases small-cell lung cancer risk by 54 times, highlighting smoking's dangers.

MEOVV: The Black Label’s First Girl Group Revealed with Stunning Logo

The Black Label's new girl group MEOVV has debuted with a striking logo and cover image, featuring a cat's paw design.

LS Electric Brings a 2,900-sq-ft AI Factory to AW 2026: Predictive Maintenance Before Machines Break

LS Electric is set to showcase its AI-powered factory model at the AW 2026 expo, aiming to transform manufacturing and enhance productivity.

Tag: Wegovy

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

Novo Nordisk’s Oral Wegovy Tops 3,000 Prescriptions in Its First Week—A Challenge to Injectable GLP-1s

Novo Nordisk's Wegovy oral treatment exceeds 3,000 prescriptions in its debut week, signaling a shift towards oral obesity medications.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Wegovy Gets Stronger: New Dose Promises Even More Weight Loss

Novo Nordisk's new high-dose Wegovy aims to enhance obesity treatment, with promising trial results and a strategic EU rollout planned.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.